Investigators Closer to Predicting 2 Common Heart Conditions

Two novel research studies from Cedars-Sinai move the needle on predicting two important heart conditions—sudden cardiac arrest, which is often fatal, and increased coronary artery calcium, a marker of coronary artery disease that can lead to a heart attack.

Mediterranean Diet Linked to Lower Preeclampsia Risk

In a new study evaluating the Mediterranean diet and adverse pregnancy outcomes, investigators from the Smidt Heart Institute at Cedars-Sinai found that women who conceived while adhering to the anti-inflammatory diet had a significantly lower risk of developing preeclampsia during pregnancy.

Immune System Irregularities Found in Women With Postpartum Mood Disorders

Women with prolonged mental health problems up to three years after childbirth may be suffering from irregular immune system responses, according to new research by Cedars-Sinai investigators. The findings are published in the American Journal of Reproductive Immunology.

Some Healthcare Workers Produced a Low Response to COVID-19 Vaccinations in a Study by Cedars-Sinai

A subset of healthcare workers vaccinated against COVID-19 had unexpectedly low responses to the immunizations, according to Cedars-Sinai investigators. The findings of the new study are published in iScience, a Cell Press journal.

Tipsheet: Cedars-Sinai Digestive Disease Experts Share Latest Research and Honors at the ACG 2022 Scientific Meeting

Cedars-Sinai physicians and scientists will share the results of new research aimed at improving the treatment of digestive diseases during the international meeting of the American College of Gastroenterology (ACG). The clinical conference will take place Oct. 21-26 in Charlotte, North Carolina, and is available for virtual and in-person attendance.

HER2 Pathways in Breast Cancer May Hold Key to Effective Treatment of Idiopathic Pulmonary Fibrosis

LOS ANGELES (Oct. 13, 2022) — FINDINGS A new study led by Cedars-Sinai investigators suggests HER2 signaling may be a key driver of fibroblast invasion and can serve as a target for therapeutic intervention in idiopathic pulmonary fibrosis. HER2 is…

Gut Gases Linked to Specific Types of Irritable Bowel Syndrome

A new study led by Cedars-Sinai investigators found using breath tests to identify gut gas profiles can potentially help lead to more personalized therapies for people diagnosed with irritable bowel syndrome (IBS). The most common gastrointestinal disorder affects 10% to15% of the world’s population.

Stem Cell-Gene Therapy Shows Promise in ALS Safety Trial

Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the blood-brain barrier. This combined stem cell and gene therapy can potentially protect diseased motor neurons in the spinal cord of patients with amyotrophic lateral sclerosis, a fatal neurological disorder known as ALS or Lou Gehrig’s disease.

Hyperactivation of the Immune System May Cause Post-COVID Syndromes

Investigators at Cedars-Sinai have proposed a theory for how SARS-CoV-2, the virus that causes COVID-19, infects the body. Their hypothesis, published in Frontiers in Immunology, could explain why some people still have symptoms long after the initial infection.

First-of-its-Kind Stem Cell and Gene Therapy Highlighted at Annual Stem Cell Meeting

Investigators from Cedars-Sinai will present the latest novel stem cell and regenerative medicine research at the International Society for Stem Cell Research (ISSCR) Annual Meeting, which is being held in person and virtually June 15-19 in San Francisco.